<DOC>
	<DOCNO>NCT01112618</DOCNO>
	<brief_summary>This non-interventional study plan identify subject severe luteinizing hormone ( LH ) deficiency daily practice . The result use `` Periodic Safety Update Report '' , regularly send European Medicines Agency ( EMEA ) responsible German Higher Federal Authority ( BfArM ) .</brief_summary>
	<brief_title>A Non-interventional Study Identify Patients With Severe Luteinizing Hormone Deficiency Daily Practice</brief_title>
	<detailed_description>Female subject distinctive follicle stimulate hormone ( FSH ) LH deficiency require FSH LH . Until subject treat either combination two recombinant preparation ( r-hFSH r-hLH ) else menotropin preparation , compose urinary human FSH ( u-hFSH ) human chorionic gonadotropin ( hCG ) LH-replacement . In Pergoverisâ„¢ first time hormone FSH LH available recombinant produce hormone combination preparation . Pergoveris hormones i.e . FSH LH available recombinant produce hormone combination preparation ratio 2:1 . This study plan record data stimulation case ovarian stimulation intercourse optimum ( VZO ) also intrauterine insemination ( IUI ) ovarian stimulation assist reproduction [ in-vitro fertilisation ( IVF ) intracytoplasmatic sperm injection ( ICSI ) ] subject severe FSH LH deficiency learn subject group apply stimulation plan . Apart demographic data , anamnestic detail e.g . reason infertility , duration unfulfilled wish child , past medical treatment conception accompany illness document . The duration stimulation Pergoveris well dose per day record cycle documentation . Follicle size hormone document accordance respectively carry cycle monitoring . The result treatment related number cycle ovulation stimulation use hCG , number cycle puncture , number cycle embryo transfer , number quality ova embryo , occur pregnancy document abortion . Multiple pregnancy birth also record . OBJECTIVES - To find reason diagnosis severe LH deficiency e.g . low endogenous LH , amenorrhea , low endometrial thickness low estradiol level .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>Female subject undergoing stimulation Pergoveris ovarian stimulation VZO IUI preparation technology assist conception IVF ICSI Subjects receive combination cycle clomifen , follitropin beta , urinary FSH , urinary human menopausal gonadotropin ( hMG )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Infertility</keyword>
	<keyword>Reproductive technology , Assisted</keyword>
	<keyword>r-hFSH</keyword>
	<keyword>r-hLH</keyword>
	<keyword>Pergoveris</keyword>
</DOC>